0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

MEDICAL NEWS

JAMA. 1967;200(3):33-46. doi:10.1001/jama.1967.03120160011003.
Text Size: A A A
Published online

ABSTRACT

Long-Term Contraception Near?  A "second generation" of contraceptive drugs, emphasizing long-term antifertility, is appearing on the clinical horizon.Planned Parenthood Physicians, meeting in Atlanta, were told:

  • Implantable, sustained release preparations, which could provide contraception for a year, may be ready for early clinical trial within six months.

  • Two injectable contraceptives so far have proven safe and acceptable in clinical trials ranging up to three years; but further study is required before general clinical use.

Discussing the possibility of implantable contraceptives, investigators from the Population Council, New York City, noted that the efficacy of daily, minute oral doses of progestogen—less than a milligram—has been proved extensively. Several field trials of this contraceptive approach have been conducted, including that in Mexico City by Jorge Martinez-Manatou, MD.Animal studies now indicate that the so-called mini-dose also can be dispensed through an implanted silastic capsule, injected microspheres, or similar techniques. "We need

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();